Human metapneumovirus vaccine (Sanofi)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Human metapneumovirus vaccine (Sanofi), covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age. [Phase 1]